0000899243-18-002039.txt : 20180125 0000899243-18-002039.hdr.sgml : 20180125 20180125200549 ACCESSION NUMBER: 0000899243-18-002039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180123 FILED AS OF DATE: 20180125 DATE AS OF CHANGE: 20180125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Panzara Michael A. CENTRAL INDEX KEY: 0001679039 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37627 FILM NUMBER: 18549654 MAIL ADDRESS: STREET 1: 733 CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wave Life Sciences Ltd. CENTRAL INDEX KEY: 0001631574 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: U0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 CROSS STREET STREET 2: #10-00 CITY: SINGAPORE STATE: U0 ZIP: 048424 BUSINESS PHONE: 617-206-4830 MAIL ADDRESS: STREET 1: 8 CROSS STREET STREET 2: #10-00 CITY: SINGAPORE STATE: U0 ZIP: 048424 FORMER COMPANY: FORMER CONFORMED NAME: WAVE Life Sciences Ltd. DATE OF NAME CHANGE: 20170516 FORMER COMPANY: FORMER CONFORMED NAME: Wave Life Sciences Ltd. DATE OF NAME CHANGE: 20151106 FORMER COMPANY: FORMER CONFORMED NAME: Wave Life Sciences LTD. DATE OF NAME CHANGE: 20151106 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-23 0 0001631574 Wave Life Sciences Ltd. WVE 0001679039 Panzara Michael A. C/O WAVE LIFE SCIENCES LTD., 733 CONCORD AVE. CAMBRIDGE MA 02138 0 1 0 0 Franchise Lead, Neurology Ordinary Shares 2018-01-23 4 A 0 17500 0.00 A 39736 D Share Option (right to buy) 40.05 2018-01-23 4 A 0 35000 0.00 A 2028-01-23 Ordinary Shares 35000 35000 D Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022. The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25% of the shares quarterly thereafter until February 15, 2022. /s/ Michael A. Panzara 2018-01-25